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Macrophages are major cellular inhabitants of cycling and pregnant mammalian uteri. Their
densities and patterns of tissue distribution in this organ fluctuate in concert with levels of
circulating female sex steroid hormones, estrogens and progesterone, and their production of
various effector molecules also may be hormonally regulated. Hormonal control may be
achieved by direct binding to receptors or by indirect pathways where hormones modulate
production of various autocrine and paracrine cytokines and growth factors that then target to
resident macrophages and influence their secretory profiles. In this paper, we marshall evidence
supporting the concept that progesterone acts as a powerful negative regulator of these versatile
cells, reducing their migration into the uterus and impairing their ability to produce potent
effector molecules such as nitric oxide that could interfere with the success of pregnancy.
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INTRODUCTION
Although macrophages have long been recognized as
major cellular inhabitants of cycling and pregnant
mammalian uteri, nearly all of the studies that have
established the fundamental characteristics of these
remarkable cells have been reported within the last
decade and a half (reviewed by Hunt, 1989; Hunt and
Pollard, 1992). Macrophage densities and distribu-
tional patterns within cycling and pregnant uteri of
rodents and women have been mapped; conditions
influencing their migration, differentiation, and
activation in the uterus have been investigated; and
some information on their secretory profiles has been
generated.
The studies done thus far indicate that essentially
all aspects of macrophages in the uterus are governed
directly or indirectly by female hormones, estrogens
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and progesterone. Environmental programming is not
novel to the uterus; in other contexts, macrophages
are affected by cytokines as well as by extracellular
matrix and cell-membrane components (Auger and
Ross, 1992; Rutherford et al., 1993). Macrophages
rapidly adapt to whatever task is at hand, and as a
consequence, are phenotypically and functionally
heterogenous.
In this paper, we present evidence in support of the
concept that uterine macrophages programmed by
female steroid hormones and the powerful cytokines
they unleash develop functional profiles appropriate
to fertility and pregnancy. The focus is on mice, a
species where compartments of the uterus are very
similar to the human and the type of placentation
(hemochorial) is the same.
exposed to comparatively high concentrations of the
hormone. A series of elegant studies by Werb and co-
workers showed that this unexpected phenomenon is
due to cross-binding of progesterone to GR (Werb,
1978; Werb et al., 1978a, 1978b). Studies done
recently in our laboratory where no additive effect
over dexamethazone alone was obtained when macro-
phages were treated with a combination of progester-
one plus dexamethazone (Miller et al., 1996) tend to
support the cross-binding interpretation. Our current
experiments are directed toward learning whether the
same types of intracellular signaling pathways such as
activation of the transcription factor inhibitor, ItBc
(Baeuerle and Henkel, 1994; Scheinman et al., 1995),
occur in progesterone- and glucocorticoid-treated
mouse macrophages.
MACROPHAGE RECEPTORS FOR
HORMONES AND CYTOKINES
The exquisite sensitivity of macrophages to environ-
mental signals is due to the presence of a wide range
of receptors for modulators such as steroid hormones,
polypeptide growth factors, cytokines, and bioactive
lipids.
Hormone Receptors
Several investigators have reported the presence of
estrogen receptors on macrophages and this was
recently verified in our laboratory by using reverse-
transcription polymerase chain reaction (RT-PCR)
(Miller et al., 1996). The mouse macrophage cell
lines, RAW264.7 and J774, as well as culture-derived
mouse bone-marrow macrophages contained estrogen
receptor (ER) mRNA. Macrophages also exhibit
abundant receptors for glucocorticoids (GR) (Auger
and Ross, 1992), but it is not entirely clear whether
the cells express androgen receptors (reviewed by
Miller and Hunt, 1996).
Classical progesterone receptors (PR) cannot be
identified on macrophages by direct binding nor can
PR mRNA be identified by RT-PCR, yet macro-
phages respond dramatically to progesterone when
Other Receptors
Macrophages exhibit receptors for a wide range of
other substances such as immunoglobulins, comple-
ment components, cytokines, colony-stimulating fac-
tors, peptides and neurotransmitters, iron-binding
proteins such as transferrin and lactoferrin, lipopro-
teins and lipids, coagulants and anticoagulants, fibro-
nectin, laminin and other adhesion molecules, sugars
and lectins. These have recently been listed and
discussed in detail by Auger and Ross (1992). Many
of these substances have been identified in the
pregnant uterus where they might influence macro-
phage behavior.
HORMONAL INFLUENCES ON
MACROPHAGE MIGRATION
The mouse estrus cycle is characterized by an
increase in the levels of circulating estrogen as the
cycle progresses from proestrus to estrus, and an
increase in the levels of circulating progesterone as
the cycle continues into diestrus-I and diestrus-II
(McCormack and Greenwald, 1974). Estrogens are
also high during the initial and final stages of mouse
pregnancy, whereas progesterone dominates during
the middle stages.REGULATION OF MACROPHAGES 107
F4/80+ macrophages increase in the uterus during
estrus and diestrus-I (Huang et al., 1995) and migrate
into the uterus following implantation (reviewed by
Hunt and Pollard, 1992), suggesting that estrogen or
estrogen-stimulated uterine growth factors such as
colony-stimulating factor- (CSF- 1) or granulocyte-
macrophage colony-stimulating factor (GM-CSF)
may promote their migration. In vitro assays to test
estrogen as a chemoattractant have not yet been
reported. However, during the early stages of preg-
nancy, macrophages continue to arrive in the uterus
even when CSF-1 and GM-CSF are absent (Hunt et
al., 1993; reviewed by Hunt and Robertson, 1996).
Possibly, chemoattraction is achieved by MIP-lc,
MIP-1/3, RANTES, or JE, all of which are transcribed
in pregnant mouse uterus (Robertson et al., in press).
Specific message is present for all of these chemoat-
tractants, but it is not yet known whether the
transcripts are translated and functional proteins are
produced.
The numbers of macrophages are dramatically
reduced in diestrus-II and proestrus uteri, and the
pregnancy-stimulated influx of macrophages appears
to be halted during the middle stages of pregnancy.
Because progesterone is high relative to estrogen
during these stages, these observations are consistent
with the idea that progesterone inhibits macrophage
migration. This could be (1) a direct hormonal effect
on the macrophage genes that promote migration such
as receptors for certain adhesion molecules, (2)
associated with reduction of uterine chemoattractants,
or (3) due to enhanced expression of molecules such
as Fas ligand that restrict migration of activated
hematopoietic cells (Griffith et al., 1995). These
possibilities remain to be explored experimentally.
POTENTIAL REGULATION OF UTERINE
MACROPHAGE ACTIVATION BY
STEROIDAL HORMONES
Uterine macrophages are known to be in an activated
state (high expression of Ia antigens) during the
periimplantation period as well as during late stages
of pregnancy (reviewed by Hunt and Robertson,
1996). Experiments are in progress to determine how
activation may be achieved.
Expression of Interferon-y Receptors
Macrophages are primarily activated by exposure to
interferon-?, (IFN-y), and there is some evidence that
female steroid hormones may facilitate this activation
pathway in mouse uterine macrophages. In situ
hybridization studies have demonstrated associations
between levels of circulating female sex steroid
hormones and the intensity of signals for IFN-y
receptor mRNA (o chain, IFN-yR) in uterine macro-
phages. Signals are elevated in diestrus relative to
other stages of the cycle, are readily detectable in the
periimplantation period, and remain high in uterine
macrophages throughout pregnancy (Chen et al.,
1994).
Presumably, increased expression of IFN-yR
would enhance the sensitivity of uterine macrophages
to activation by IFN-y, but this has not been
demonstrated experimentally in the uterus.
IFN-T in Mouse Uterus
The question then arises as to whether or not IFN-y is
present in cycling and/or pregnant mouse uterus. Lin
et al. (1993) showed that IFN-y is detectable in early
postimplantation mouse uteroplacental units by
ELISA, and limited RT-PCR analyses conducted in
our laboratory indicate that the IFN-y gene is
transcribed at both early (day 6) and late (day 18)
stages of mouse pregnancy (Platt and Hunt, 1996).
The cellular source(s) of IFN-y are as yet unclear
but might include uterine natural killer cells (uNK). In
other contexts, NK cells initiate immune responses
with IFN-y production (Sheehan and Schreiber,
1992). Alternatively, mouse placental trophoblast
cells may produce IFN-y as is the case in the pig and
human (LeFevre et al., 1990; Haynes et al., 1993).
Interestingly and of potential relevance to pregnancy,
the IFN-y gene itself is hormonally regulated; estro-
gen activates the IFN-y promoter (Fox et al., 1991).
Cause-and-effect relationships between IFN-y and
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yet to be established. Although both IFN-T- and IFN-
yR-deficient mice are available their uteri have not
been examined for the presence of Ia+ macrophages.
It is entirely possible that pregnancy goes forward in
these knockout mice because other types of inter-
ferons (Bazer et al., 1994; Hager et al., 1994; Whaley
et al., 1994) and/or tumor necrosis factor-ce (TNFc0
(reviewed by Hunt et al., 1996) substitute for IFN-
3/.
HORMONAL REGULATION OF
MACROPHAGE SECRETORY PROFILES
A limited number of observations point to regulation
of uterine macrophage secretions by female hormones
and/or the cytokines they control. The data collected
thus far are consistent with the idea that progesterone
programs uterine macrophages into a suppressive
profile.
Studies Conducted In Vivo
Macrophages in pregnant mouse uterus are major
sites of production of the anti-inflammatory, immuno-
suppressive lipid, prostaglandin E2 (PGE2) (Tawfik et
al., 1986; reviewed by Hunt, 1992). Two additional
anti-inflammatory cytokines, transforming growth
factor-/31 and interleukin-10 (IL-10), are produced in
mouse and rat uterus (Chen et al., 1993; Lin et al.,
1993) but have not been established as arising from
uterine macrophages. By contrast, during most of
pregnancy in rats and mice, uterine macrophages
contain mRNA for the cytokine, TNFce, but little
TNFce protein (Hunt et al., 1993), suggesting an
inhibition of production of this proinflammatory
cytokine.
Studies on Mouse Macrophage Cell Lines
Recently, we have turned to macrophage cell lines as
models for studying the impact of female sex steroid
hormones on macrophage secretory profiles. Nitric
oxide (NO) is a major product of activated macro-
phages that might have a detrimental effect if
produced in high amounts during pregnancy and
might, therefore, be one of the proinflammatory
molecules that should be restricted. It is, therefore, of
considerable interest and potential importance to
pregnancy that progesterone inhibits production of
this potent molecule.
In macrophages, NO is produced following activa-
tion of the inducible nitric oxide synthase (iNOS)
gene. We tested the ability of estrogens and progester-
one singly and in combination, dexamethazone (posi-
tive control) and neutral lipids (negative controls), as
well as estrogen and progesterone analogs to influ-
ence activation of the iNOS gene promoter, steady-
state levels of iNOS transcripts, and production ofNO
(Miller and Hunt, 1996). These experiments utilized
several strategies, including transient transfection of
promoter constructs into RAW264.7 mouse macro-
phages and northern blots as well as substrate
conversion assays in RAW264.7 cells, J774 cells, and
cultured mouse bone-marrow macrophages.
The results of these studies showed clearly that
despite the absence of detectable PR mRNA proges-
terone efficiently downregulates all three phases, that
is, iNOS gene activation, accumulation of specific
mRNA, and production of NO. This finding is
consistent with a previous report from our laboratory,
which demonstrated that progesterone downregulates
iNOS in uterine mast cells (Huang et al., 1995), as
well as the observation that progesterone inhibits the
ability of macrophages to kill target cells (Feinberg et
al., 1992).
SUMMARY
The data accumulated thus far are consistent with the
proposition that estrogens promote an active macro-
phage profile and progesterone promotes a suppressor
macrophage profile. However, it is as yet uncertain
whether this putative principle will hold true under
changing conditions of pregnancy, when concentra-
tions of certain macrophage-targeting cytokines and
growth factors fluctuate.
It is critical also to recognize that although
experimentation in this area furthers our under-REGULATION OF MACROPHAGES 109
standing of how female steroidal hormones operate
during pregnancy, the results could have broader
implications. Because hormones circulate freely in the
blood and macrophages are located in all tissues and
organs, estrogens and progesterone are likely to have
major influences on the overall immune competence
in females of child-bearing age. It is, therefore,
imperative to develop a full understanding of the
conditions that drive tissue macrophages into the
suppressive mode where reactivity against infections
and tumors could be reduced.
Acknowledgments
The authors thank the technical assistants, students,
and postdoctoral fellows who have contributed to this
work. The studies were supported in part by grants
from the National Institutes of Health to J.S.H.
(HD24212, HD25691), the Kansas Mental Retarda-
tion Research Center (HD02528), and the Kansas
Center for Reproductive Sciences P30 Core Grant
(HD33994).
References
Auger M.J., and Ross J.A. (1992). The biology of the macrophage.
In The Macrophage, Lewis C.E., and McGee J.O’D., Eds.
(Oxford: Oxford University Press), pp. 3-74.
Baeuerle P.A., and Henkel T. (1994). Function and activation of
NF-KB in the immune system. Annu. Rev. Immunol. 12:
141-179.
Bazer F.W., Spencer T.E., Ott T.L., and Johnson H.M. (1994).
Cytokines and pregnancy recognition. In Immunobiology of
Reproduction, Hunt J.S., Ed. (New York: Springer-Verlag), pp.
37-56.
Chen H.-L., Kamath R., Pace J.L., Russell S.W., and Hunt J.S.
(1994). Gestation-related expression of the interferon-y receptor
gene in mouse uterine and embryonic hematopoietic cells. J.
Leukocyte Biol. 55: 617-625.
Chen H.-L., Yelavarthi K.K., Hu X.-L., and Hunt J.S. (1993).
Identification of transforming growth factor-/31 mRNA in virgin
and pregnant rats by in situ hybridization. J. Reprod. Immunol.
25: 221-233.
Feinberg B.B., Tan N.S., Walsh S.W., Brath P.C., and Gonik B.
(1992). Progesterone and estradiol suppress human mononuclear
cell cytotoxicity. J. Reprod. Immunol. 21: 139-142.
Fox H.S., Bond B.L., and Parslow T.G. (1991). Estrogen regulates
the IFN-y promoter. J. Immunol. 146: 4362-4367.
Griffith T.S., Brunner T., Fletcher S.M., Green D.R., and Ferguson
T.A. (1995). Fas ligand-induced apoptosis as a mechanism of
immune privilege. Science 270:1189-1192.
Hager H., Aboagye-Mathiesen G., Petersen P.M., Norskov-
Loritsen 388?, Juhl C.B., Villadsen J.A., Zdravkovic M.,
Gildberg A., Dalsgaard A.M., and Ebbesen P. (1994). Human
trophoblast interferons enhance major histocompatibility com-
plex class antigen expression on human term trophoblast cells
in culture. Placenta 15: 709-714.
Haynes M.K., Jackson L.G., Tuan R.S., Shepley K.J., and Smith
J.B. (1993). Cytokine production in first trimester chorionic villi:
Detection of mRNAs and protein products in situ. Cell.
Immunol. 151: 300-308.
Huang J., Roby K.F., Pace J.L., and Hunt J.S. (1995). Localization
and hormonal regulation of inducible nitric oxide synthase in
cycling mouse uterus. J. Leukocyte Biol. 57: 27-35.
Hunt J.S. (1989). Cytokine networks in the uteroplacental unit:
Macrophages as pivotal regulatory cells. J. Reprod. Immunol.
16: 1-17.
Hunt J.S. (1992). Prostaglandins, immunoregulation, and macro-
phage function. In Immunological Obstetrics, Coulam C., Faulk
W.P., and McIntyre J.A., Eds. (New York: Norton), pp. 73-84.
Hunt J.S., Chen H.-L., and Miller L. (1996). Tumor necrosis
factors: Pivotal factors in pregnancy? Biol. Reprod. 54:
554-562.
Hunt J.S., Chen H.-L., Hu X.-L., and Pollard J.W. (1993). Normal
distribution of tumor necrosis factor-a messenger ribonucleic
acid and protein in virgin and pregnant osteopetrotic (op/op)
mice. Biol. Reprod. 49: 441-452.
Hunt J.S., and Pollard J.W. (1992). Macrophages in the uterus and
placenta. In Current Topics in Microbiology and Immunology,
Macrophages and Macrophage Activation, Gordon S., and
Russell S.W., Eds. (Heidelberg: Springer-Verlag), pp. 39-63.
Hunt J.S., and Robertson S.A. (1996). Uterine macrophages and
environmental programming for pregnancy success. J. Reprod.
Immunol. 32: 1-25.
LeFevre F., Martinat-Botte F., Guillomot M., Zouari M., Charley
B., and La Bonnardiere C. (1990). Interferon-y gene and protein
are spontaneously expressed by the porcine trophectoderm early
in gestation. Eur. J. Immunol. 20: 2485-2490.
Lin H., Mosmann T.R., Guilbert L., Tuntipopipat S., and Wegmann
T. (1993). Synthesis of T helper 2-type cytokines at the
maternal-fetal interface. J. Immunol. 151: 4562-4573.
McCormack J.T., and Greenwald G.S. (1974). Progesterone and
oestradiol-17/3 concentrations in the peripheral plasma during
pregnancy in the mouse. J. Endocrinol. 62: 101-107.
Miller L., Alley E.W., Murphy W.J., Russell S.W., and Hunt J.S.
(1996). Progesterone inhibits inducible nitric oxide synthase
gene expression and nitric oxide production in murine macro-
phages. J. Leukocyte Biol. 59: 442-450.
Miller L., and Hunt J.S. (1996). Sex steroid hormones and
macrophage function. Life Sci. 59: 1-14.
Platt J.S., and Hunt J.S. (1996). Immunoreactive interferon-y in
cycling and pregnant mouse uterus. Biol. Reprod. 54 (Suppl. 1):
84.
Robertson S.A., Mau V.J. and Tramellen K.T. (In press). Cytokine-
leukocyte networks and the establishment of pregnancy. Troph.
Res.
Rutherford M.S., Witsell A., and Schook L.B. (1993). Mechanisms
generating functionally heterogeneous macrophages: Chaos
revisited. J. Leukocyte Biol. 53: 602-618.
Scheinman R.I., Cogswell P.C., Lofquist A.K., and Baldwin A. Jr.
(1995). Role of transcriptional activation of ItcBa in mediation
of immunosuppression by glucocortocoids. Science 270:
283-286.110 J.S. HUNT et al.
Sheehan K.C.F., and Schreiber R.D. (1992). The synergy and Werb Z., Foley R., and Munck A. (1978a). Interaction of
antagonism of interferon-y and TNF. In Tumor Necrosis glucocorticoids with macrophages. J. Exp. Med. 147:
Factors, Beutler B., Ed. (New York: Raven Press), pp. 1684-1694.
145-178. Werb Z., Foley R., and Munck A. (1978b). Glucocorticoid
Tawfik O.W., Hunt J.S., and Wood G.W. (1986). Implication of receptors and glucocorticoid-sensitive secretion of neutral pro-
prostaglandin E2 in soluble factor-mediated immune suppres- teinases in a macrophage line. J. Immunol. 121:115-121.
sion by murine decidual cells. Amer. J. Reprod. Immunol. WhaleyA.E., ReddyMekaC.S., Hunt J.S., and ImakawaK. (1994).
Microbiol. 12:111-117. Identification and cellular localization of unique interferon
Werb Z. (1978). Biochemical actions of glucocorticoids on mRNA from human placenta. J. Biol. Chem. 269:
macrophages in culture. J. Exp. Med. 147: 1695-1712. 10864-10868.